CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo
Cancer Research and Treatment. 2019;51(3):901-909.   Published online 2018 October 4    DOI: https://doi.org/10.4143/crt.2018.326

Excel Download

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Cancer Research and Treatment. 2019;51(3):901-909   Crossref logo
Link1 Link2 Link3

P-106Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patients
Annals of Oncology. 2018;29(suppl_5):   Crossref logo
Link1

Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer
Asia-Pacific Journal of Clinical Oncology. 2016;13(1):13-20   Crossref logo
Link1 Link2 Link3

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Surgery. 2011;2011:310-312   Crossref logo
Link1 Link2

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Gastroenterology. 2010;2010:96-97   Crossref logo
Link1 Link2

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study
Chemotherapy. 2013;59(3):232-238   Crossref logo
Link1 Link2

Practical Use of Gemcitabine and Cisplatin Combination Therapy as First-Line Treatment for Japanese Patients with Advanced Biliary Tract Cancer
Journal of Cancer Therapy. 2013;04(06):1068-1073   Crossref logo
Link1 Link2 Link3

Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
Value in Health. 2013;16(7):A416   Crossref logo
Link1 Link2

766PPrognostic factors in patients with advanced biliary tract cancer (BTC) who showed durable disease control with first-line gemcitabine plus cisplatin (GemCis)
Annals of Oncology. 2018;29(suppl_8):   Crossref logo
Link1

767PPredictive factors of outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Annals of Oncology. 2018;29(suppl_8):   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.